hCCAR2, previously called DBC1, was initially found to exhibit homozygous deletion in breast cancer43, suggesting a tumor-suppressive role, but later studies found hCCAR2 expression to be increased in various cancer types, suggesting an oncogenic role44. Here, CCAR2 is linked to neoplasm.